Display options
Cite
Lei J, Deng H, Ran Y, et al. Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease. Cartilage. 2020;13(1):818S-828Sdoi: 10.1177/1947603520932199.
Lei, J., Deng, H., Ran, Y., Lv, Y., Amhare, A. F., Wang, L., Guo, X., Han, J., & Lammi, M. J. (2021). Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease. Cartilage, 13(1), 818S-828S. https://doi.org/10.1177/1947603520932199
Lei, Jian, et al. "Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease." Cartilage vol. 13,1 (2021): 818S-828S. doi: https://doi.org/10.1177/1947603520932199
Lei J, Deng H, Ran Y, Lv Y, Amhare AF, Wang L, Guo X, Han J, Lammi MJ. Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease. Cartilage. 2021 Dec;13(1):818S-828S. doi: 10.1177/1947603520932199. Epub 2020 Jun 09. PMID: 32517548.
Copy Download .nbib Format: NLM
Share it on

Cartilage. 2021 Dec;13(1):818S-828S. doi: 10.1177/1947603520932199. Epub 2020 Jun 09.

Altered Expression of Aggrecan, FAM20B, B3GALT6, and EXTL2 in Patients with Osteoarthritis and Kashin-Beck Disease.

Cartilage

Jian Lei, Huan Deng, Yan Ran, Yizhen Lv, Abebe Feyissa Amhare, Liyun Wang, Xiong Guo, Jing Han, Mikko J Lammi

Affiliations

  1. School of Public Health, Key Laboratory of Environment and Genes Related to Diseases, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
  2. Shenzhen Institute, Xi'an Jiaotong University, Shenzhen, Guangdong, People's Republic of China.
  3. Department of Gastroenterology, the First Affiliated Hospital, Health Science Center of Xi'an Jiaotong University, Xi'an, People's Republic of China.
  4. Department of Integrative Medical Biology, Umeå University, Umeå, Sweden.

PMID: 32517548 DOI: 10.1177/1947603520932199

Abstract

OBJECTIVE: The objective of this study was to investigate the expression of enzymes involved in synthesis and modification of chondroitin sulfate (CS) in knee cartilage tissue of patients with osteoarthritis (OA) and Kashin-Beck disease (KBD).

METHODS: The knee articular cartilage samples were obtained from 18 age- and gender-matched donors with 6 each in KBD, OA, and control groups. Hematoxylin and eosin (HE) staining, toluidine blue (TB) staining, and immunohistochemical (IHC) staining were performed to estimate the expression level and localization of aggrecan, along with FAM20B, GalT-II, and EXTL2, which are associated with CS synthesis and modification. Rank-based analyses of variance test was used for the multiple comparisons of discrepancy in the positive staining rate among the 3 groups.

RESULTS: In HE and TB staining results, damaged morphology, decreased chondrocyte numbers and proteoglycans were observed in OA and KBD groups compared with the control group. In line with these trends, the positive staining rates of aggrecan were lower in KBD and OA groups than in the control group. Meanwhile, the positive staining rates of CS chain modifying enzymes FAM20B, GalT-II, and EXTL2 decreased in OA and KBD groups.

CONCLUSIONS: In conclusion, it was demonstrated that altered expression of CS chain modifying enzymes in OA and KBD groups influenced the synthesis procession of CS and could contribute to the damage of cartilage. Further investigation of these enzymes can provide new theoretical and experimental targets for OA and KBD pathogenesis studies.

Keywords: Kashin-Beck disease; cartilage; chondroitin sulfate; immunohistochemistry; osteoarthritis

Publication Types